We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -1.04% | 2.375 | 2.30 | 2.45 | 2.40 | 2.375 | 2.40 | 607,520 | 09:00:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.53 | 13.04M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/9/2024 11:21 | This bit is very important for this small company: "with the goal of enabling transition from conditional to full recommendation by NICE, which in turn is expected to facilitate funding for the test at a national level." | themachine2 | |
06/9/2024 11:16 | zico Good factual info Hopefully that will keep Batiatus from posting porkies on this thread | themachine2 | |
06/9/2024 10:45 | In March 2023, the Genedrive® MT-RNR1-ID Kit received a recommendation for use in the UK by the National Institute for Health and Care Excellence ("NICE") under its Early Value Assessment Programme ("EVA"). The EVA was introduced to allow rapid assessment of digital products, devices and diagnostics for clinical effectiveness and value for money, so that the NHS and patients can benefit from these promising technologies sooner. The recommendation is conditional on further evidence being generated and the Company is a partner with clinical colleagues at Manchester University NHS Foundation Trust ("MFT") who have recently applied for funding to address the NICE EVA evidence generation recommendations, which are required for progressing the NICE conditional recommendation into a full recommendation at the earliest opportunity. | z1co | |
06/9/2024 10:44 | You gone quiet , i thought you would Lets posts some FACTS: The Genedrive® MT-RNR1 test received conditional recommendation from the UK's National Institute for Health and Care Excellence ("NICE") in March 2023, enabling its use in the NHS whilst further evidence is generated. Plans for generating the required further evidence are underway, with the goal of enabling transition from conditional to full recommendation by NICE, which in turn is expected to facilitate funding for the test at a national level. | z1co | |
06/9/2024 10:34 | Batti You THICKO what are you on about July ? Are you making reference to CYP2C19 or MT-RNR1 ? You are very confused , been spending too much time posting LIES | z1co | |
06/9/2024 10:18 | "You THICKO that will happen once the NICE guidance becomes FULL from conditional." How do you know it WILL go to Full Recommendation? You have been saying that even before July. You were very adamant that Full Recommendation would be given in July. The result? It didn't happen. | batiatus | |
06/9/2024 10:15 | "There is no public information on the reasons behind JC's leaving. Stating reasons why as "the only explanation" is nothing more than supposition." Of course they will say that. GDR isn't gonna say Cheek left the company because our kits have flopped are they | batiatus | |
06/9/2024 09:45 | Last news was announced on 12th August nearly 4 weeks ago , we are due some more positive news very soon and lets hope it arrives next week. | z1co | |
06/9/2024 09:31 | There is no public information on the reasons behind JC's leaving. Stating reasons why as "the only explanation" is nothing more than supposition. The investor presentation which can be accessed from the link below gives an excellent summary of prospects. | chatchat | |
06/9/2024 09:30 | Sensible comment! | eggbaconandbubble | |
06/9/2024 09:29 | Well said! | eggbaconandbubble | |
06/9/2024 09:27 | With funding out of the way the news from the company will only get BETTER. Contract news will be next hopefully next week followed by EVA news next month which should take the price well above 3p again. | z1co | |
06/9/2024 09:23 | From the man who spends the majority of his time posting meaningless and annoying rants about beeksy, batti boy et al. (as well as some occasional good stuff) ‘Pot’ and ‘kettle’ come to mind!!! Cut the chaff ffs and MORE wheat. Please. Pretty please!!! | eggbaconandbubble | |
06/9/2024 09:23 | Batti You THICKO that will happen once the NICE guidance becomes FULL from conditional. The NIHR i4i & OLS Real World Evidence Programme is intended to address each eligible EVA, is being led by Office for Life Sciences ("OLS") as part of the UK Government's Life Sciences Vision and is backed by £10m of government funding and is expected to commence in October 2024. Sales RAMP UP will happen from next financial year starting 01/07/2025 and management are also forecasting EBITDA positive from H2. Do some research instead of posting LIES all the time Hope this helps you THICKO | z1co | |
06/9/2024 09:19 | And must I add, if GDR was about to hit the jackpot, why did James Cheek leave the company? Surely he wants his name on the achievement It DOESN'T make sense! The only explanation is James Cheek knows these kits won't get anywhere! | batiatus | |
06/9/2024 09:15 | Does anyone actually read the repetitive duplicated posts that Z1co posts LOL If the kits were that good then how come there hasn't been more contract sales But Z1co is sure of more sales but just doesn't know when, and when it arrives it will be life changing Errrm....sound like the Euro millions to me. When you hit the jackpot it will be life changing...but the problem is winning the jackpot (sales contracts in this case) | batiatus | |
06/9/2024 08:47 | eggy Just ask yourself do you post anything worthwhile other than your one liners like the one you posted above. FFS man post something useful about the company or it's product instead of making sarcastic remarks about me I remember even on the CSFS you never really contributed anything worthwhile. You've just slapped an egg on your own face!!! Hope that helps you | z1co | |
06/9/2024 08:35 | SICO - you do post some good stuff from time to time, but it's always a case of sorting the wheat from the chaff!!! | eggbaconandbubble |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions